JP2005501805A - Ｔｈｅｒｍｕｓ科の微生物の発酵によるタンパク質の生成のためのプロセス、このようにして得られたタンパク質の混合物、およびそれらを含有する美容用組成物 - Google Patents
Ｔｈｅｒｍｕｓ科の微生物の発酵によるタンパク質の生成のためのプロセス、このようにして得られたタンパク質の混合物、およびそれらを含有する美容用組成物 Download PDFInfo
- Publication number
- JP2005501805A JP2005501805A JP2002566372A JP2002566372A JP2005501805A JP 2005501805 A JP2005501805 A JP 2005501805A JP 2002566372 A JP2002566372 A JP 2002566372A JP 2002566372 A JP2002566372 A JP 2002566372A JP 2005501805 A JP2005501805 A JP 2005501805A
- Authority
- JP
- Japan
- Prior art keywords
- cosmetic
- skin
- pharmaceutical composition
- protein
- dermatological pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 36
- 239000000203 mixture Substances 0.000 title claims abstract description 31
- 238000000855 fermentation Methods 0.000 title claims abstract description 19
- 230000004151 fermentation Effects 0.000 title claims abstract description 19
- 244000005700 microbiome Species 0.000 title claims abstract description 17
- 241000589596 Thermus Species 0.000 title claims abstract description 10
- 102000004169 proteins and genes Human genes 0.000 title claims description 33
- 108090000623 proteins and genes Proteins 0.000 title claims description 33
- 238000000034 method Methods 0.000 title claims description 22
- 238000004519 manufacturing process Methods 0.000 title claims description 13
- 230000008569 process Effects 0.000 title claims description 13
- 230000000694 effects Effects 0.000 claims abstract description 25
- 210000004209 hair Anatomy 0.000 claims abstract description 12
- -1 oxygen peroxide Chemical class 0.000 claims abstract description 10
- 229940106189 ceramide Drugs 0.000 claims abstract description 6
- 210000004761 scalp Anatomy 0.000 claims abstract description 6
- 210000000987 immune system Anatomy 0.000 claims abstract description 5
- 108010006519 Molecular Chaperones Proteins 0.000 claims abstract description 4
- 239000013535 sea water Substances 0.000 claims abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 claims description 19
- 239000006071 cream Substances 0.000 claims description 11
- 230000032683 aging Effects 0.000 claims description 7
- 230000009931 harmful effect Effects 0.000 claims description 7
- 206010063493 Premature ageing Diseases 0.000 claims description 6
- 208000032038 Premature aging Diseases 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 230000002225 anti-radical effect Effects 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 6
- 238000011282 treatment Methods 0.000 claims description 6
- 230000002789 catalaselike Effects 0.000 claims description 5
- 230000002255 enzymatic effect Effects 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 239000006210 lotion Substances 0.000 claims description 5
- 230000001681 protective effect Effects 0.000 claims description 5
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 4
- 229940041514 candida albicans extract Drugs 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 239000003094 microcapsule Substances 0.000 claims description 4
- 239000011859 microparticle Substances 0.000 claims description 4
- 239000002088 nanocapsule Substances 0.000 claims description 4
- 239000002105 nanoparticle Substances 0.000 claims description 4
- 230000009759 skin aging Effects 0.000 claims description 4
- 239000012138 yeast extract Substances 0.000 claims description 4
- HYPYXGZDOYTYDR-HAJWAVTHSA-N 2-methyl-3-[(2e,6e,10e,14e)-3,7,11,15,19-pentamethylicosa-2,6,10,14,18-pentaenyl]naphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 HYPYXGZDOYTYDR-HAJWAVTHSA-N 0.000 claims description 3
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 3
- 102000005431 Molecular Chaperones Human genes 0.000 claims description 3
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 3
- 239000000839 emulsion Substances 0.000 claims description 3
- 150000002632 lipids Chemical class 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 239000008267 milk Substances 0.000 claims description 3
- 235000013336 milk Nutrition 0.000 claims description 3
- 210000004080 milk Anatomy 0.000 claims description 3
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 230000000475 sunscreen effect Effects 0.000 claims description 3
- 239000000516 sunscreening agent Substances 0.000 claims description 3
- 239000004094 surface-active agent Substances 0.000 claims description 3
- 238000003786 synthesis reaction Methods 0.000 claims description 3
- 238000000108 ultra-filtration Methods 0.000 claims description 3
- 235000019143 vitamin K2 Nutrition 0.000 claims description 3
- 239000011728 vitamin K2 Substances 0.000 claims description 3
- 229940041603 vitamin k 3 Drugs 0.000 claims description 3
- 108010004103 Chylomicrons Proteins 0.000 claims description 2
- 102000008186 Collagen Human genes 0.000 claims description 2
- 108010035532 Collagen Proteins 0.000 claims description 2
- 244000062730 Melissa officinalis Species 0.000 claims description 2
- 235000010654 Melissa officinalis Nutrition 0.000 claims description 2
- 239000000729 antidote Substances 0.000 claims description 2
- 239000000440 bentonite Substances 0.000 claims description 2
- 229910000278 bentonite Inorganic materials 0.000 claims description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 claims description 2
- 229920001436 collagen Polymers 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 239000003995 emulsifying agent Substances 0.000 claims description 2
- 239000004744 fabric Substances 0.000 claims description 2
- 239000000835 fiber Substances 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims description 2
- 230000013595 glycosylation Effects 0.000 claims description 2
- 238000006206 glycosylation reaction Methods 0.000 claims description 2
- 230000002401 inhibitory effect Effects 0.000 claims description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 2
- 239000000865 liniment Substances 0.000 claims description 2
- 239000002502 liposome Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 235000010755 mineral Nutrition 0.000 claims description 2
- 235000015097 nutrients Nutrition 0.000 claims description 2
- 239000003921 oil Substances 0.000 claims description 2
- 229920000620 organic polymer Polymers 0.000 claims description 2
- 239000000419 plant extract Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 239000002453 shampoo Substances 0.000 claims description 2
- 239000000344 soap Substances 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 239000012209 synthetic fiber Substances 0.000 claims description 2
- 229920002994 synthetic fiber Polymers 0.000 claims description 2
- 239000000454 talc Substances 0.000 claims description 2
- 229910052623 talc Inorganic materials 0.000 claims description 2
- 230000000699 topical effect Effects 0.000 claims description 2
- 235000013619 trace mineral Nutrition 0.000 claims description 2
- 239000011573 trace mineral Substances 0.000 claims description 2
- 239000013598 vector Substances 0.000 claims description 2
- 210000002268 wool Anatomy 0.000 claims description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims 2
- 235000019270 ammonium chloride Nutrition 0.000 claims 1
- 239000003599 detergent Substances 0.000 claims 1
- 238000009629 microbiological culture Methods 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 230000005855 radiation Effects 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 239000002562 thickening agent Substances 0.000 claims 1
- 239000001301 oxygen Substances 0.000 abstract description 4
- 229910052760 oxygen Inorganic materials 0.000 abstract description 4
- 150000001783 ceramides Chemical class 0.000 abstract description 3
- 238000001784 detoxification Methods 0.000 abstract description 3
- 210000003491 skin Anatomy 0.000 description 21
- 239000002609 medium Substances 0.000 description 18
- 239000001963 growth medium Substances 0.000 description 7
- 239000002028 Biomass Substances 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 239000000126 substance Substances 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 230000000670 limiting effect Effects 0.000 description 4
- 102000016938 Catalase Human genes 0.000 description 3
- 108010053835 Catalase Proteins 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 description 3
- 108010012715 Superoxide dismutase Proteins 0.000 description 3
- 101000867659 Bos taurus Catalase Proteins 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- 101150013553 CD40 gene Proteins 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 206010073310 Occupational exposures Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 208000007180 Sunstroke Diseases 0.000 description 1
- 241000589499 Thermus thermophilus Species 0.000 description 1
- 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000007707 calorimetry Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002431 foraging effect Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 231100000675 occupational exposure Toxicity 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 238000000751 protein extraction Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 241000556533 uncultured marine bacterium Species 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Cosmetics (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0102442A FR2821086B1 (fr) | 2001-02-21 | 2001-02-21 | Procede de fabrication de proteines par fermentation de microorganismes de la famille thermus, melange de proteines ainsi obtenu et composition cosmetique les contenant |
| PCT/FR2002/000488 WO2002066668A2 (fr) | 2001-02-21 | 2002-02-07 | Procede de fabrication de proteines par fermentation de micro-organismes de la famille thermus, melange de proteines ainsi obtenu et composition cosmetiques les contenant. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005501805A true JP2005501805A (ja) | 2005-01-20 |
| JP2005501805A5 JP2005501805A5 (https=) | 2005-12-22 |
Family
ID=8860339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002566372A Pending JP2005501805A (ja) | 2001-02-21 | 2002-02-07 | Ｔｈｅｒｍｕｓ科の微生物の発酵によるタンパク質の生成のためのプロセス、このようにして得られたタンパク質の混合物、およびそれらを含有する美容用組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20040115766A1 (https=) |
| EP (1) | EP1392840A2 (https=) |
| JP (1) | JP2005501805A (https=) |
| AU (1) | AU2002235994A1 (https=) |
| FR (1) | FR2821086B1 (https=) |
| WO (1) | WO2002066668A2 (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010504299A (ja) * | 2006-09-20 | 2010-02-12 | シャネル パフュームズ ビューテ | マトリプターゼ発現を刺激する活性剤の化粧上での使用 |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2843023B1 (fr) * | 2002-07-30 | 2004-09-24 | Sederma Sa | Compositions cosmetiques ou dermopharmaceutiques contenant du kombucha. |
| FR2843879B1 (fr) * | 2002-08-27 | 2005-12-30 | Svr Lab | Nouvelles compositions cosmetiques a visee anti-oxydante |
| EP1725246A4 (en) * | 2004-01-30 | 2009-07-15 | E L Management Corp | COMPOSITIONS WITH INTERNAL ACTIVATED ANTIOXIDANE |
| FR2869229B1 (fr) * | 2004-04-26 | 2006-08-25 | Sederma Soc Par Actions Simpli | Utilisation d'un inducteur des ugt par voie topique |
| FR2880802B1 (fr) * | 2005-01-14 | 2008-12-19 | Sederma Soc Par Actions Simpli | Composition cosmetique ou dermopharmaceutique contenant un extrait d'euglene |
| FR2885522B1 (fr) * | 2005-05-13 | 2020-01-10 | Sederma | Composition cosmetique ou dermopharmaceutique contenant de la teprenone |
| FR2890310B1 (fr) | 2005-09-06 | 2009-04-03 | Sederma Soc Par Actions Simpli | Utilisation des protoberberines comme agents regulant l'activite de l'unite pilosebacee |
| FR2900573B1 (fr) * | 2006-05-05 | 2014-05-16 | Sederma Sa | Nouvelles compositions cosmetiques renfermant au moins un peptide contenant au moins un cycle aromatique bloque |
| FR2904549B1 (fr) * | 2006-08-03 | 2012-12-14 | Sederma Sa | Composition comprenant de la sarsasapogenine |
| FR2939799B1 (fr) | 2008-12-11 | 2011-03-11 | Sederma Sa | Composition cosmetique comprenant des oligoglucuronanes acetyles. |
| EP3744729B1 (en) | 2009-01-16 | 2023-03-01 | Sederma | Peptides, compositions comprising them and cosmetic and dermopharmaceutical uses |
| FR2941231B1 (fr) | 2009-01-16 | 2016-04-01 | Sederma Sa | Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques. |
| FR2941232B1 (fr) | 2009-01-16 | 2014-08-08 | Sederma Sa | Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques. |
| FR2944435B1 (fr) | 2009-04-17 | 2011-05-27 | Sederma Sa | Composition cosmetique comprenant de l'oridonine |
| FR2945939B1 (fr) | 2009-05-26 | 2011-07-15 | Sederma Sa | Utilisation cosmetique du dipeptide tyr-arg pour lutter contre le relachement cutane. |
| US9737472B2 (en) | 2010-08-09 | 2017-08-22 | Allele Biotechnology & Pharmaceuticals, Inc. | Light-absorbing compositions and methods of use |
| US10842728B2 (en) | 2010-08-09 | 2020-11-24 | Allele Biotechnology & Pharmaceuticals, Inc. | Light-absorbing compositions and methods of use |
| US9205284B2 (en) | 2010-08-09 | 2015-12-08 | Allele Biotechnology & Pharmaceuticals, Inc. | Light-absorbing compositions and methods of use |
| FR2970868B1 (fr) | 2011-01-31 | 2023-10-27 | Sederma Sa | Extrait d'origine vegetale, composition le contenant, procede d'obtention par culture vegetale et utilisations dans les domaines cosmetique, pharmaceutique et cosmeceutique |
| FR2975904B1 (fr) | 2011-06-01 | 2013-08-23 | Sederma Sa | Nouvelle utilisation topique, cosmetique ou dermopharmaceutique, d'un melange comprenant un tripeptide du type ghk et un tetrapeptide du type gqpr |
| FR2978351B1 (fr) | 2011-07-28 | 2014-02-21 | Sederma Sa | Materiel d'origine vegetale, composition le contenant, et utilisation topique cosmetique |
| FR2985424B1 (fr) | 2012-01-10 | 2019-03-29 | Sederma | Nouvelle utilisation topique de la zerumbone |
| FR2997299B1 (fr) | 2012-10-30 | 2014-12-26 | Sederma Sa | Association d'extraits de plantes, ingredient actif cosmetique et composition les contenant, et utilisation topique cosmetique |
| FR2998570B1 (fr) | 2012-11-26 | 2016-12-02 | Sederma Sa | Peptides, compositions les comprenant et utilisations notamment cosmetiques propigmentantes |
| WO2014167464A1 (en) | 2013-04-08 | 2014-10-16 | Sederma | Production method of meristematic cells of plantago lanceolata, composition comprising said cells or their cellular extract, and cosmetic, nutraceutical and dermatological uses |
| FR3004351B1 (fr) * | 2013-04-16 | 2015-03-27 | Sederma Sa | Prevention et traitement des dommages cutanes lies aux infra-rouges |
| FR3018449B1 (fr) | 2014-03-17 | 2017-09-01 | Sederma Sa | Utilisation cosmetique d'un extrait de mirabilis jalapa, ingredient actif et composition cosmetique correspondantes |
| FR3021319B1 (fr) | 2014-05-22 | 2018-08-31 | Sederma | Peptides, compositions les comprenant et utilisations notamment cosmetiques |
| US20160000682A1 (en) | 2014-07-02 | 2016-01-07 | Geoffrey Brooks Consultants Llc | Peptide-Based Compositions and Methods of Use |
| FR3024037B1 (fr) | 2014-07-25 | 2018-03-02 | Sederma | Ingredient actif cosmetique ou dermatologique comprenant un melange d'acides dicarboxyliques gras insatures, compositions le comprenant et utilisations cosmetiques ou dermatologiques |
| FR3029782B1 (fr) | 2014-12-16 | 2019-06-07 | Sederma | Composes peptidiques, compositions les comprenant et utilisations notamment cosmetiques |
| FR3029915B1 (fr) | 2014-12-16 | 2016-12-09 | Sederma Sa | Tripeptides, compositions les comprenant et utilisations notamment cosmetiques |
| FR3031454B1 (fr) | 2015-01-13 | 2018-05-11 | Sederma | Utilisation de cellules vegetales de leontopodium alpinum pour un traitement cosmetique et ingredient actif cosmetique correspondant |
| US20170326062A1 (en) | 2016-05-13 | 2017-11-16 | Yi-Chun Lin | Compositions for skin application |
| US10383809B2 (en) | 2017-01-13 | 2019-08-20 | Galactic Beauty, LLC | Skin treatment compositions, masks and related methods |
| FR3101542B1 (fr) | 2019-10-04 | 2022-10-28 | Sederma Sa | UTILISATION DE cellules VÉGÉTALES de LEONTODIUM ALPINUM POUR UN TRAITEMENT cosmÉtique ANTIGLYCATION |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3219792B2 (ja) * | 1991-09-04 | 2001-10-15 | 三省製薬株式会社 | 皮膚老化防止用外用剤 |
| US5405767A (en) * | 1992-04-08 | 1995-04-11 | Solvay Enzymes, Inc. | Purified enzyme concentrate and method of preparation |
| US5739156A (en) * | 1994-09-21 | 1998-04-14 | The Procter & Gamble Company | Methods of using 2,4-dienoic acid esters of tocopherols to reduce free radical damage in mammalian cells |
| US5969121A (en) * | 1996-01-11 | 1999-10-19 | Thermogen, Inc. | Stable biocatalysts for ester hydrolysis |
| FR2783169B1 (fr) * | 1998-09-15 | 2001-11-02 | Sederma Sa | Utilisation cosmetique ou dermopharmaceutique de peptides pour la cicatrisation et pour l'amelioration de l'aspect cutane lors du vieillissement naturel ou accelere (heliodermie, pollution) |
-
2001
- 2001-02-21 FR FR0102442A patent/FR2821086B1/fr not_active Expired - Lifetime
-
2002
- 2002-02-07 US US10/468,081 patent/US20040115766A1/en not_active Abandoned
- 2002-02-07 JP JP2002566372A patent/JP2005501805A/ja active Pending
- 2002-02-07 EP EP02702466A patent/EP1392840A2/fr not_active Ceased
- 2002-02-07 WO PCT/FR2002/000488 patent/WO2002066668A2/fr not_active Ceased
- 2002-02-07 AU AU2002235994A patent/AU2002235994A1/en not_active Abandoned
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010504299A (ja) * | 2006-09-20 | 2010-02-12 | シャネル パフュームズ ビューテ | マトリプターゼ発現を刺激する活性剤の化粧上での使用 |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2821086B1 (fr) | 2003-12-12 |
| WO2002066668A2 (fr) | 2002-08-29 |
| US20040115766A1 (en) | 2004-06-17 |
| WO2002066668A3 (fr) | 2003-12-18 |
| AU2002235994A1 (en) | 2002-09-04 |
| FR2821086A1 (fr) | 2002-08-23 |
| EP1392840A2 (fr) | 2004-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005501805A (ja) | Ｔｈｅｒｍｕｓ科の微生物の発酵によるタンパク質の生成のためのプロセス、このようにして得られたタンパク質の混合物、およびそれらを含有する美容用組成物 | |
| KR102237543B1 (ko) | 알로에 속 식물 유래 dna의 제조방법, 및 알로에 속 식물 유래 dna를 유효성분으로 포함하는 항노화 및 항염증용 조성물 | |
| JP2005501805A5 (https=) | ||
| TW201919581A (zh) | 用於改善皮膚、頭髮及頭皮健康之基於酵母菌之膜 | |
| KR102195365B1 (ko) | 쌀배아 발효 추출물을 이용한 피부개선용 보습화장료 조성물 | |
| KR102119825B1 (ko) | 현미, 녹차 및 포공영 발효 추출물을 포함하는 피부 내 마이크로바이옴 균형 유지용 화장료 조성물 및 이의 제조 방법 | |
| ES2543351T3 (es) | Preparación de principios activos cosméticos por cultivo de Vitreoscilla en agua termal y composiciones que los comprenden | |
| CN1812795A (zh) | 外用组成物 | |
| KR20190091161A (ko) | 동백씨 발효 추출물을 포함하는 모발 상태 개선용 화장료 조성물 | |
| EP2976060A1 (en) | Exopolysaccharide for the treatment and/or care of the skin, mucous membranes and/or nails | |
| WO2020203933A1 (ja) | 抗老化剤、抗酸化剤、抗炎症剤、及び美白剤、並びに、化粧料 | |
| KR101841118B1 (ko) | 세네데스무스 속 미세조류의 추출물을 유효성분으로 함유하는 피부 외용제 조성물 | |
| KR20230112127A (ko) | 피부 질환의 미생물 치료를 위한 방법 및 조성물 | |
| CN102892404B (zh) | 豌豆的肽水解产物作为保湿活性剂的用途 | |
| JP7534759B2 (ja) | 抗酸化剤、抗糖化剤、ヒアルロニダーゼ阻害剤、および、化粧料 | |
| KR102405854B1 (ko) | 바람꽃 유래 락토바실러스 쿤키 Hankook-001 균주 및 상기 균주를 포함하는 피부 보습 및 주름 개선용 화장료 조성물 | |
| CN103930560A (zh) | 从藻类中生产4-氨基丁酸的方法 | |
| KR102098871B1 (ko) | 역미셀을 형성하는 발효유화제를 이용한 안티인플라메이징 조성물 | |
| WO2020096059A1 (ja) | 育毛用又は脱毛防止用外用剤 | |
| KR101806007B1 (ko) | 나노화된 천연 성분이 함유된 화장료 조성물의 제조방법 및 그 제조방법을 통해 제조되는 화장료 조성물 | |
| CN117448236A (zh) | 暹罗芽孢杆菌及其应用的用于强化皮肤屏障的化妆品合成物 | |
| CN1253495A (zh) | 用于脱除皮肤或其表面生长物的色素的酚衍生物和鸢尾科植物萃取物的组合和包括这种组合的组合物 | |
| KR102139000B1 (ko) | 발효 식이유황 추출물을 함유하는 항산화, 항주름, 미백 및 항균 기능성 화장료 조성물 및 그 제조방법 | |
| JP2022031140A (ja) | 皮膚外用剤 | |
| KR102903469B1 (ko) | 락토바실러스 브레비스 j2k-55 균주 유래 세포외 소포체를 함유하는 피부 장벽 개선용 화장료 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A072 | Dismissal of procedure [no reply to invitation to correct request for examination] |
Free format text: JAPANESE INTERMEDIATE CODE: A072 Effective date: 20041209 |